Parathyroid hormone
- Generic Name
- Parathyroid hormone
- Brand Names
- Natpara, Natpar
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9002-64-6
- Unique Ingredient Identifier
- N19A0T0E5J
- Background
Parathyroid hormone (PTH) is a single-chain polypeptide composed of 84 amino acids. Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence, leaving the mature protein as a single-chain 84 amino-acids polypeptide...
- Indication
For use/treatment in osteoporosis.
- Associated Conditions
- Hypocalcemia, Hypoparathyroidism
- Associated Therapies
- -
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2000-03-27
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Helen Hayes Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT00005006
- Locations
- 🇺🇸
Helen Hayes Hospital, Clinical Research Center, West Haverstraw, New York, United States
Effects of Parathyroid Hormone in Men With Osteoporosis
Phase 3
Completed
- Conditions
- First Posted Date
- 2000-01-19
- Last Posted Date
- 2013-12-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 81
- Registration Number
- NCT00000427
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath